Livermore

NovaBridge Biosciences

NBP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001778016

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
Sep 21, 20264:05 PM ETSep 18, 2026Dennis Phillip AndrewChief Medical OfficerSSaleOrdinary Shares−8.21K$0.71−$5.83K173.43K−4.5%SEC
Sep 11, 20264:30 PM ETSep 9, 2026Cao Sean WuxiongChief Bus. Development OfficerSSaleOrdinary Shares−107.98K$0.74−$79.9K266.47K−28.8%SEC
Sep 1, 20266:00 PM ETAug 31, 2026Xu Cong ClaireEVP, Clinical DevelopmentSSaleOrdinary Shares−3.28K$0.79−$2.59K304.2K−1.1%SEC
Jul 7, 20267:50 PM ETJul 6, 2026Xu Cong ClaireSVP, Clinical DevelopmentSSaleOrdinary Shares−4.49K$0.89−$3.99K298.1K−1.5%SEC
Jun 22, 2026Jun 18, 2026Dennis Phillip AndrewChief Medical OfficerSSaleOrdinary Shares−8.49K$0.66−$5.61K157.94K−5.1%SEC
Jun 2, 2026Jun 1, 2026Xu Cong ClaireSVP, Clinical DevelopmentSSaleOrdinary Shares−3.49K$3.94−$13.77K290.15K−1.2%SEC
May 18, 2026May 14, 2026Cao Sean WuxiongSee RemarksSSaleOrdinary Shares−21.4K$1.99−$42.58K35.07K−37.9%SEC
Apr 28, 2026Apr 24, 2026Hagler Mark ArnoldSee RemarksPPurchaseOrdinary Shares+230K$2.51+$577.3K230KNew positionSEC